Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes.
Saved in:
| Title: | Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes. |
|---|---|
| Authors: | Sharma A; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, Ohio, USA., Mariam A; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, Ohio, USA., Zacherle E; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Milinovich A; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Bauman J; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Sugano DS; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Noone J; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Rajpura JR; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Zimmerman RS; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA., Burguera B; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA., Kattan MW; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Misra-Hebert AD; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Healthcare Delivery and Implementation Science Center, Cleveland Clinic, Cleveland, Ohio, USA., Pantalone KM; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA., Rotroff DM; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Center for Quantitative Metabolic Research, Cleveland Clinic, Cleveland, Ohio, USA.; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Nov; Vol. 26 (11), pp. 5347-5357. Date of Electronic Publication: 2024 Aug 27. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.15896 |
